. Author manuscript; available in PMC: 2015 Jun 1.

Published in final edited form as: Osteoporos Int. 2014 Mar 29;25(6):1677–1684. doi: 10.1007/s00198-014-2662-0

Table 1. Participant characteristics from hip fracture analysis of warfarin use ≥1 year among older adults with atrial fibrillation.

Characteristics	Warfarin users (N=10,173)	Warfarin nonusers (N=10,173)
Age, mean (SD) (years)	77.7 (6.1)	77.6 (6.7)
Sex (% women)	48.0	48.0
BMI, mean (SD) (kg/m²)	27.2 (5.0)	27.2 (5.2)
DVT (%)	2.3	2.2
PE (%)	1.5	1.2
Heart failure (%)	21.0	20.5
High fall risk (%)	3.2	3.1
Hyperthyroidism (%)	2.7	2.5
Neuro-psychiatric impairment (%)	1.7	1.2
Current smokers (%)	7.7	7.5
Alcoholics (%)	0.2	0.2
Beta-blockers (%)	56.0	56.0
Bisphosphonates (%)	6.9	6.8
Diuretics (%)	65.5	65.0
Estrogen (%)	3.0	3.0
Glucocorticoids (%)	17.1	17.2
Statins (%)	47.9	48.1
Follow-up time, mean (SD) (days)	1,155 (868.6)	1,105 869.9)
Propensity score (mean)	0.2	0.2
Deaths (%)	20.9	23.9

DVT deep venous thrombosis, PE pulmonary embolism